Gérald Gavory
Impact in
-
- Ubiquitin and proteasome pathways
- Advanced biosensing and bioanalysis techniques
- Protein Degradation and Inhibitors
- RNA Interference and Gene Delivery
- DNA and Nucleic Acid Chemistry
- Histone Deacetylase Inhibitors Research
-
- Cancer-related Molecular Pathways
Papers in
-
- RNA Interference and Gene Delivery 5
- Ubiquitin and proteasome pathways 4
- Advanced biosensing and bioanalysis techniques 4
- DNA and Nucleic Acid Chemistry 3
- Oncology 7
- Cancer-related Molecular Pathways 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Shankar Balasubramanian (5 shared papers)C. O'Dowd (7 shared papers)Oliver Barker (4 shared papers)Natalie Page (4 shared papers)Timothy Harrison (4 shared papers)Matthew Helm (3 shared papers)Hugues Miel (2 shared papers)Keeva McClelland (3 shared papers)
- Journals
- Cancer Research (4 papers)Biochemistry (2 papers)Scientific Reports (2 papers)Chemical Communications (1 paper)Nature Chemical Biology (1 paper)
- Partner nations
- United KingdomUnited StatesSouth Sudan
In The Last Decade
Gérald Gavory
15 papers receiving 397 citations
Peers
Comparison fields: 5 of 47
- Molecular Biology 360
- Oncology 118
- Physiology 47
- Epidemiology 46
- Genetics 35
Countries citing papers authored by Gérald Gavory
This map shows the geographic impact of Gérald Gavory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Gavory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Gavory more than expected).
Fields of papers citing papers by Gérald Gavory
This network shows the impact of papers produced by Gérald Gavory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Gavory. The network helps show where Gérald Gavory may publish in the future.
Co-authors
The 25 scholars most cited alongside Gérald Gavory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 171 | |
| 2 | 2018 | 54 | |
| 3 | 2004 | 43 | |
| 4 | 2002 | 30 | |
| 5 | 2002 | 25 | |
| 6 | 2006 | 23 | |
| 7 | 2004 | 20 | |
| 8 | 2024 | 10 | |
| 9 | 2022 | 10 | |
| 10 | 2019 | 5 | |
| 11 | 2015 | 2 | |
| 12 | Mebendazole: A candidate FDA approved drug for repurposing in leukaemia | 2016 | 2 |
| 13 | 2010 | 1 | |
| 14 | 2016 | 1 | |
| 15 | PNA and Oligonucleotide Inhibitors of Human Telomerase | 2013 | 1 |
| 16 | 2024 | 0 |
About Gérald Gavory
Gérald Gavory is a scholar working on Molecular Biology, Oncology, Physiology, Cell Biology and Organic Chemistry, having authored 16 papers that have together received 398 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Ubiquitin and proteasome pathways (4 papers), Telomeres, Telomerase, and Senescence (4 papers), Cancer-related Molecular Pathways (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), DNA and Nucleic Acid Chemistry (3 papers), Microtubule and mitosis dynamics (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Molecular Biology (360 citations), Oncology (118 citations), Physiology (47 citations), Epidemiology (46 citations) and Genetics (35 citations). Gérald Gavory has collaborated with scholars based in United Kingdom, United States and South Sudan. Frequent co-authors include Shankar Balasubramanian, C. O'Dowd, Oliver Barker, Natalie Page, Timothy Harrison, Matthew Helm, Hugues Miel, Keeva McClelland, Jakub Flasz and Mark Isalan. Their work appears in journals such as Cancer Research, Biochemistry, Scientific Reports, Chemical Communications and Nature Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.